Global PD-1 and PD-L1 Monoclonal Antibody Market Growth 2024-2031

Report ID: 1767456 | Published Date: Jan 2025 | No. of Page: 102 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for PD-1 and PD-L1 Monoclonal Antibody by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for PD-1 and PD-L1 Monoclonal Antibody by Country/Region, 2017, 2022 & 2028
    2.2 PD-1 and PD-L1 Monoclonal Antibody Segment by Type
        2.2.1 PD-1
        2.2.2 PD-L1
    2.3 PD-1 and PD-L1 Monoclonal Antibody Sales by Type
        2.3.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2022)
        2.3.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue and Market Share by Type (2017-2022)
        2.3.3 Global PD-1 and PD-L1 Monoclonal Antibody Sale Price by Type (2017-2022)
    2.4 PD-1 and PD-L1 Monoclonal Antibody Segment by Application
        2.4.1 Lung Cancer
        2.4.2 Liver Cancer
        2.4.3 Esophageal Cancer
        2.4.4 Gastric Cancer
        2.4.5 Nasopharyngeal Carcinoma
        2.4.6 Head and Neck Cancer
        2.4.7 Other
    2.5 PD-1 and PD-L1 Monoclonal Antibody Sales by Application
        2.5.1 Global PD-1 and PD-L1 Monoclonal Antibody Sale Market Share by Application (2017-2022)
        2.5.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue and Market Share by Application (2017-2022)
        2.5.3 Global PD-1 and PD-L1 Monoclonal Antibody Sale Price by Application (2017-2022)
3 Global PD-1 and PD-L1 Monoclonal Antibody by Company
    3.1 Global PD-1 and PD-L1 Monoclonal Antibody Breakdown Data by Company
        3.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Annual Sales by Company (2020-2022)
        3.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Company (2020-2022)
    3.2 Global PD-1 and PD-L1 Monoclonal Antibody Annual Revenue by Company (2020-2022)
        3.2.1 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Company (2020-2022)
        3.2.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Company (2020-2022)
    3.3 Global PD-1 and PD-L1 Monoclonal Antibody Sale Price by Company
    3.4 Key Manufacturers PD-1 and PD-L1 Monoclonal Antibody Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers PD-1 and PD-L1 Monoclonal Antibody Product Location Distribution
        3.4.2 Players PD-1 and PD-L1 Monoclonal Antibody Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for PD-1 and PD-L1 Monoclonal Antibody by Geographic Region
    4.1 World Historic PD-1 and PD-L1 Monoclonal Antibody Market Size by Geographic Region (2017-2022)
        4.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Annual Revenue by Geographic Region
    4.2 World Historic PD-1 and PD-L1 Monoclonal Antibody Market Size by Country/Region (2017-2022)
        4.2.1 Global PD-1 and PD-L1 Monoclonal Antibody Annual Sales by Country/Region (2017-2022)
        4.2.2 Global PD-1 and PD-L1 Monoclonal Antibody Annual Revenue by Country/Region
    4.3 Americas PD-1 and PD-L1 Monoclonal Antibody Sales Growth
    4.4 APAC PD-1 and PD-L1 Monoclonal Antibody Sales Growth
    4.5 Europe PD-1 and PD-L1 Monoclonal Antibody Sales Growth
    4.6 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Growth
5 Americas
    5.1 Americas PD-1 and PD-L1 Monoclonal Antibody Sales by Country
        5.1.1 Americas PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022)
        5.1.2 Americas PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022)
    5.2 Americas PD-1 and PD-L1 Monoclonal Antibody Sales by Type
    5.3 Americas PD-1 and PD-L1 Monoclonal Antibody Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC PD-1 and PD-L1 Monoclonal Antibody Sales by Region
        6.1.1 APAC PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2017-2022)
        6.1.2 APAC PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2017-2022)
    6.2 APAC PD-1 and PD-L1 Monoclonal Antibody Sales by Type
    6.3 APAC PD-1 and PD-L1 Monoclonal Antibody Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe PD-1 and PD-L1 Monoclonal Antibody by Country
        7.1.1 Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022)
        7.1.2 Europe PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022)
    7.2 Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Type
    7.3 Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody by Country
        8.1.1 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022)
        8.1.2 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022)
    8.2 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Type
    8.3 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Monoclonal Antibody
    10.3 Manufacturing Process Analysis of PD-1 and PD-L1 Monoclonal Antibody
    10.4 Industry Chain Structure of PD-1 and PD-L1 Monoclonal Antibody
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 PD-1 and PD-L1 Monoclonal Antibody Distributors
    11.3 PD-1 and PD-L1 Monoclonal Antibody Customer
12 World Forecast Review for PD-1 and PD-L1 Monoclonal Antibody by Geographic Region
    12.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Region
        12.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Forecast by Region (2023-2028)
        12.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global PD-1 and PD-L1 Monoclonal Antibody Forecast by Type
    12.7 Global PD-1 and PD-L1 Monoclonal Antibody Forecast by Application
13 Key Players Analysis
    13.1 Merk
        13.1.1 Merk Company Information
        13.1.2 Merk PD-1 and PD-L1 Monoclonal Antibody Product Offered
        13.1.3 Merk PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Merk Main Business Overview
        13.1.5 Merk Latest Developments
    13.2 Bristol-Myers Squibb Company
        13.2.1 Bristol-Myers Squibb Company Company Information
        13.2.2 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product Offered
        13.2.3 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Bristol-Myers Squibb Company Main Business Overview
        13.2.5 Bristol-Myers Squibb Company Latest Developments
    13.3 Roche
        13.3.1 Roche Company Information
        13.3.2 Roche PD-1 and PD-L1 Monoclonal Antibody Product Offered
        13.3.3 Roche PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Roche Main Business Overview
        13.3.5 Roche Latest Developments
    13.4 Pfizer
        13.4.1 Pfizer Company Information
        13.4.2 Pfizer PD-1 and PD-L1 Monoclonal Antibody Product Offered
        13.4.3 Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Pfizer Main Business Overview
        13.4.5 Pfizer Latest Developments
    13.5 AstraZeneca
        13.5.1 AstraZeneca Company Information
        13.5.2 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product Offered
        13.5.3 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 AstraZeneca Main Business Overview
        13.5.5 AstraZeneca Latest Developments
    13.6 Junshi Biosciences
        13.6.1 Junshi Biosciences Company Information
        13.6.2 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product Offered
        13.6.3 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Junshi Biosciences Main Business Overview
        13.6.5 Junshi Biosciences Latest Developments
    13.7 Innovent
        13.7.1 Innovent Company Information
        13.7.2 Innovent PD-1 and PD-L1 Monoclonal Antibody Product Offered
        13.7.3 Innovent PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Innovent Main Business Overview
        13.7.5 Innovent Latest Developments
    13.8 Hengrui
        13.8.1 Hengrui Company Information
        13.8.2 Hengrui PD-1 and PD-L1 Monoclonal Antibody Product Offered
        13.8.3 Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Hengrui Main Business Overview
        13.8.5 Hengrui Latest Developments
    13.9 BeiGene
        13.9.1 BeiGene Company Information
        13.9.2 BeiGene PD-1 and PD-L1 Monoclonal Antibody Product Offered
        13.9.3 BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 BeiGene Main Business Overview
        13.9.5 BeiGene Latest Developments
    13.10 Alphamab Oncology
        13.10.1 Alphamab Oncology Company Information
        13.10.2 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product Offered
        13.10.3 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Alphamab Oncology Main Business Overview
        13.10.5 Alphamab Oncology Latest Developments
    13.11 Cstone
        13.11.1 Cstone Company Information
        13.11.2 Cstone PD-1 and PD-L1 Monoclonal Antibody Product Offered
        13.11.3 Cstone PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Cstone Main Business Overview
        13.11.5 Cstone Latest Developments
    13.12 Akeso
        13.12.1 Akeso Company Information
        13.12.2 Akeso PD-1 and PD-L1 Monoclonal Antibody Product Offered
        13.12.3 Akeso PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Akeso Main Business Overview
        13.12.5 Akeso Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. PD-1 and PD-L1 Monoclonal Antibody Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. PD-1 and PD-L1 Monoclonal Antibody Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of PD-1
    Table 4. Major Players of PD-L1
    Table 5. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2022) & (Units)
    Table 6. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2022)
    Table 7. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Type (2017-2022) & ($ million)
    Table 8. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Type (2017-2022)
    Table 9. Global PD-1 and PD-L1 Monoclonal Antibody Sale Price by Type (2017-2022) & (US$/Unit)
    Table 10. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2022) & (Units)
    Table 11. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2022)
    Table 12. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Application (2017-2022)
    Table 13. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Application (2017-2022)
    Table 14. Global PD-1 and PD-L1 Monoclonal Antibody Sale Price by Application (2017-2022) & (US$/Unit)
    Table 15. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Company (2020-2022) & (Units)
    Table 16. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Company (2020-2022)
    Table 17. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Company (2020-2022)
    Table 19. Global PD-1 and PD-L1 Monoclonal Antibody Sale Price by Company (2020-2022) & (US$/Unit)
    Table 20. Key Manufacturers PD-1 and PD-L1 Monoclonal Antibody Producing Area Distribution and Sales Area
    Table 21. Players PD-1 and PD-L1 Monoclonal Antibody Products Offered
    Table 22. PD-1 and PD-L1 Monoclonal Antibody Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Geographic Region (2017-2022) & (Units)
    Table 26. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share Geographic Region (2017-2022)
    Table 27. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Country/Region (2017-2022) & (Units)
    Table 30. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country/Region (2017-2022)
    Table 31. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022) & (Units)
    Table 34. Americas PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2017-2022)
    Table 35. Americas PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2017-2022)
    Table 37. Americas PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2022) & (Units)
    Table 38. Americas PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2022)
    Table 39. Americas PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2022) & (Units)
    Table 40. Americas PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2022)
    Table 41. APAC PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2017-2022) & (Units)
    Table 42. APAC PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2017-2022)
    Table 43. APAC PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Region (2017-2022)
    Table 45. APAC PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2022) & (Units)
    Table 46. APAC PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2022)
    Table 47. APAC PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2022) & (Units)
    Table 48. APAC PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2022)
    Table 49. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022) & (Units)
    Table 50. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2017-2022)
    Table 51. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2017-2022)
    Table 53. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2022) & (Units)
    Table 54. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2022)
    Table 55. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2022) & (Units)
    Table 56. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022) & (Units)
    Table 58. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2022) & (Units)
    Table 62. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2022) & (Units)
    Table 64. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of PD-1 and PD-L1 Monoclonal Antibody
    Table 66. Key Market Challenges & Risks of PD-1 and PD-L1 Monoclonal Antibody
    Table 67. Key Industry Trends of PD-1 and PD-L1 Monoclonal Antibody
    Table 68. PD-1 and PD-L1 Monoclonal Antibody Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. PD-1 and PD-L1 Monoclonal Antibody Distributors List
    Table 71. PD-1 and PD-L1 Monoclonal Antibody Customer List
    Table 72. Global PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Region (2023-2028) & (Units)
    Table 73. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Forecast by Region
    Table 74. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Country (2023-2028) & (Units)
    Table 77. Americas PD-1 and PD-L1 Monoclonal Antibody Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Region (2023-2028) & (Units)
    Table 79. APAC PD-1 and PD-L1 Monoclonal Antibody Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Country (2023-2028) & (Units)
    Table 81. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Country (2023-2028) & (Units)
    Table 83. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Type (2023-2028) & (Units)
    Table 85. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Application (2023-2028) & (Units)
    Table 89. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Merk Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
    Table 93. Merk PD-1 and PD-L1 Monoclonal Antibody Product Offered
    Table 94. Merk PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 95. Merk Main Business
    Table 96. Merk Latest Developments
    Table 97. Bristol-Myers Squibb Company Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
    Table 98. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product Offered
    Table 99. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 100. Bristol-Myers Squibb Company Main Business
    Table 101. Bristol-Myers Squibb Company Latest Developments
    Table 102. Roche Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
    Table 103. Roche PD-1 and PD-L1 Monoclonal Antibody Product Offered
    Table 104. Roche PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 105. Roche Main Business
    Table 106. Roche Latest Developments
    Table 107. Pfizer Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
    Table 108. Pfizer PD-1 and PD-L1 Monoclonal Antibody Product Offered
    Table 109. Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 110. Pfizer Main Business
    Table 111. Pfizer Latest Developments
    Table 112. AstraZeneca Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
    Table 113. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product Offered
    Table 114. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 115. AstraZeneca Main Business
    Table 116. AstraZeneca Latest Developments
    Table 117. Junshi Biosciences Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
    Table 118. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product Offered
    Table 119. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 120. Junshi Biosciences Main Business
    Table 121. Junshi Biosciences Latest Developments
    Table 122. Innovent Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
    Table 123. Innovent PD-1 and PD-L1 Monoclonal Antibody Product Offered
    Table 124. Innovent PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 125. Innovent Main Business
    Table 126. Innovent Latest Developments
    Table 127. Hengrui Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
    Table 128. Hengrui PD-1 and PD-L1 Monoclonal Antibody Product Offered
    Table 129. Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 130. Hengrui Main Business
    Table 131. Hengrui Latest Developments
    Table 132. BeiGene Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
    Table 133. BeiGene PD-1 and PD-L1 Monoclonal Antibody Product Offered
    Table 134. BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 135. BeiGene Main Business
    Table 136. BeiGene Latest Developments
    Table 137. Alphamab Oncology Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
    Table 138. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product Offered
    Table 139. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 140. Alphamab Oncology Main Business
    Table 141. Alphamab Oncology Latest Developments
    Table 142. Cstone Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
    Table 143. Cstone PD-1 and PD-L1 Monoclonal Antibody Product Offered
    Table 144. Cstone PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 145. Cstone Main Business
    Table 146. Cstone Latest Developments
    Table 147. Akeso Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
    Table 148. Akeso PD-1 and PD-L1 Monoclonal Antibody Product Offered
    Table 149. Akeso PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 150. Akeso Main Business
    Table 151. Akeso Latest Developments
List of Figures
    Figure 1. Picture of PD-1 and PD-L1 Monoclonal Antibody
    Figure 2. PD-1 and PD-L1 Monoclonal Antibody Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global PD-1 and PD-L1 Monoclonal Antibody Sales Growth Rate 2017-2028 (Units)
    Figure 7. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of PD-1
    Figure 10. Product Picture of PD-L1
    Figure 11. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type in 2021
    Figure 12. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Type (2017-2022)
    Figure 13. PD-1 and PD-L1 Monoclonal Antibody Consumed in Lung Cancer
    Figure 14. Global PD-1 and PD-L1 Monoclonal Antibody Market: Lung Cancer (2017-2022) & (Units)
    Figure 15. PD-1 and PD-L1 Monoclonal Antibody Consumed in Liver Cancer
    Figure 16. Global PD-1 and PD-L1 Monoclonal Antibody Market: Liver Cancer (2017-2022) & (Units)
    Figure 17. PD-1 and PD-L1 Monoclonal Antibody Consumed in Esophageal Cancer
    Figure 18. Global PD-1 and PD-L1 Monoclonal Antibody Market: Esophageal Cancer (2017-2022) & (Units)
    Figure 19. PD-1 and PD-L1 Monoclonal Antibody Consumed in Gastric Cancer
    Figure 20. Global PD-1 and PD-L1 Monoclonal Antibody Market: Gastric Cancer (2017-2022) & (Units)
    Figure 21. PD-1 and PD-L1 Monoclonal Antibody Consumed in Nasopharyngeal Carcinoma
    Figure 22. Global PD-1 and PD-L1 Monoclonal Antibody Market: Nasopharyngeal Carcinoma (2017-2022) & (Units)
    Figure 23. PD-1 and PD-L1 Monoclonal Antibody Consumed in Head and Neck Cancer
    Figure 24. Global PD-1 and PD-L1 Monoclonal Antibody Market: Head and Neck Cancer (2017-2022) & (Units)
    Figure 25. PD-1 and PD-L1 Monoclonal Antibody Consumed in Other
    Figure 26. Global PD-1 and PD-L1 Monoclonal Antibody Market: Other (2017-2022) & (Units)
    Figure 27. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2022)
    Figure 28. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Application in 2021
    Figure 29. PD-1 and PD-L1 Monoclonal Antibody Revenue Market by Company in 2021 ($ Million)
    Figure 30. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Company in 2021
    Figure 31. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Geographic Region (2017-2022)
    Figure 32. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Geographic Region in 2021
    Figure 33. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2017-2022)
    Figure 34. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country/Region in 2021
    Figure 35. Americas PD-1 and PD-L1 Monoclonal Antibody Sales 2017-2022 (Units)
    Figure 36. Americas PD-1 and PD-L1 Monoclonal Antibody Revenue 2017-2022 ($ Millions)
    Figure 37. APAC PD-1 and PD-L1 Monoclonal Antibody Sales 2017-2022 (Units)
    Figure 38. APAC PD-1 and PD-L1 Monoclonal Antibody Revenue 2017-2022 ($ Millions)
    Figure 39. Europe PD-1 and PD-L1 Monoclonal Antibody Sales 2017-2022 (Units)
    Figure 40. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue 2017-2022 ($ Millions)
    Figure 41. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales 2017-2022 (Units)
    Figure 42. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue 2017-2022 ($ Millions)
    Figure 43. Americas PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country in 2021
    Figure 44. Americas PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country in 2021
    Figure 45. United States PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Canada PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Mexico PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Brazil PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 49. APAC PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region in 2021
    Figure 50. APAC PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Regions in 2021
    Figure 51. China PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Japan PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 53. South Korea PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Southeast Asia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 55. India PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Australia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 57. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country in 2021
    Figure 58. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country in 2021
    Figure 59. Germany PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 60. France PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 61. UK PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 62. Italy PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Russia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country in 2021
    Figure 65. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country in 2021
    Figure 66. Egypt PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 67. South Africa PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 68. Israel PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 69. Turkey PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 70. GCC Country PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)
    Figure 71. Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Monoclonal Antibody in 2021
    Figure 72. Manufacturing Process Analysis of PD-1 and PD-L1 Monoclonal Antibody
    Figure 73. Industry Chain Structure of PD-1 and PD-L1 Monoclonal Antibody
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global PD-1 and PD-L1 Monoclonal Antibody Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global PD-1 and PD-L1 Monoclonal Antibody Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global PD-1 and PD-L1 Monoclonal Antibody Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports